Name: 글로벌 시장 동향
SKU: MD4229
Availability: InStock

보고서 요약(국문)

시장 개요
전 세계 심장마비 진단 시장은 2022년 87억 4,460만 달러 규모에 달했으며, 2030년까지 156억 530만 달러에 이를 것으로 예상되어 높은 성장세를 보일 전망입니다. 전 세계 심장마비 진단 시장은 예측 기간(2023~2030년) 동안 연평균 7.7%의 성장률을 기록할 것으로 예상됩니다.
전 세계 심장마비 진단 시장은 식습관, 환경적 요인, 유전적 소인 등 여러 변수의 영향을 받습니다. 이러한 요인들은 고혈압, 고콜레스테롤, 비만, 당뇨병 등을 유발하여 심혈관 질환의 위험을 증가시킬 수 있습니다.
또한 흡연, 과도한 음주, 패스트푸드 과다 섭취와 같은 건강에 해로운 습관은 심장마비 발생률에 큰 영향을 미칩니다. 이러한 해로운 습관의 확산으로 인해 심장마비 발병률이 증가하고 있습니다.

시장 동향
신제품 출시 시 활용되는 주요 조치 채택
심장마비 진단 시장은 의료비 지출 증가, 주요 업체 간의 파트너십 및 협력, 연구 개발 투자 확대 등의 요인에 힘입어 성장하고 있습니다.
예를 들어, 2022년 11월, 미국 최대 규모의 가상 진료 중심 심혈관 전문 기업인 Heartbeat Health와 심장 질환 치료의 새로운 기준을 개발하는 스타트업 Cleerly는 정밀 심장 건강 기술을 활용하여 심혈관 질환 위험을 더욱 정확하게 평가하고 더 나은 심장 치료를 제공하기 위한 파트너십을 발표했습니다. Cleerly의 AI 기반 관상동맥 컴퓨터 단층촬영 혈관조영술(CCTA) 분석 방식을 통해 의사들은 심장 동맥 벽의 죽상경화증(플라크 축적)을 더욱 신속하게 인식, 설명 및 측정할 수 있게 됩니다.
또한, 2022년 11월, 자동화 부품, 장비 및 시스템 제조 및 판매 기업인 OMRON Healthcare와 CardioSignal은 인구 건강 관리의 최전선에 있는 의사들에게 심혈관 질환 조기 발견 분야의 획기적인 기술을 제공하기 위해 협력했습니다.

두 회사는 협력하여 생활습관성 만성질환, 특히 심혈관 질환의 1차 진료 진단을 위한 워크플로 절차를 개선하는 디지털 헬스 솔루션을 개발할 것입니다. 주요 기업들의 전략은 이러한 방식으로 시장 성장을 촉진할 것입니다.
숙련된 인력 부족이 시장 성장을 저해할 것입니다.
심장 카테터 시술은 높은 수준의 정밀도와 정확성을 요구하는 고난도 시술이므로, 효율적인 시술을 위해서는 고도의 자격증을 소지하고 숙련된 경험이 풍부한 의료 전문가 팀이 필요합니다.
예측 기간 동안, 특히 신흥 국가에서 체계적인 교육 프로그램이 부족하여 관상동맥 조영술을 시행할 숙련된 전문가가 부족해 시장 성장이 다소 제한될 것으로 예상됩니다.
코로나19 영향 분석
SARS-CoV-2 바이러스 유행은 전 세계적인 봉쇄를 초래했고 심장마비 진단에 심각한 영향을 미쳤습니다. 심장 질환이 있는 사람, 특히 심장마비 위험이 높은 사람은 바이러스에 감염될 가능성이 더 높으며, 감염을 조기에 발견하지 못하면 사망 위험이 매우 높습니다.

또한, 신속한 진단 부족으로 인한 장기적인 심혈관 건강 악화에 대한 우려가 큽니다. 심혈관 질환 진단 및 치료에 대한 환자 접근성을 좌우하는 관련 당사자가 많지 않습니다.
러시아-우크라이나 전쟁 영향 분석
러시아-우크라이나 전쟁은 해당 지역의 주요 시장 참여자 부재로 인해 전 세계 심장마비 진단 시장에 미치는 영향이 미미할 것으로 예상됩니다. 그러나 원자재, 검사 제품 및 장비의 수출입은 예측 기간 동안 전 세계 심장마비 진단 시장에 거의 영향을 미치지 않을 것으로 예상됩니다.
인공지능(AI) 영향 분석
인공지능은 전 세계 심장마비 진단 시장에 긍정적인 영향을 미칠 것으로 예상됩니다. AI 알고리즘은 의료 기록, 실험실 결과, 영상 스캔 및 유전 정보 등 방대한 양의 환자 데이터를 분석할 수 있기 때문입니다. AI는 이러한 데이터를 처리하여 인간 의사가 알아차리지 못할 수 있는 패턴과 미묘한 지표를 식별함으로써 보다 정확하고 신뢰할 수 있는 심장마비 진단을 내릴 수 있습니다.
AI 알고리즘은 실시간으로 데이터를 분석하여 심장마비를 신속하고 정확하게 진단할 수 있습니다. 이는 특히 시간이 중요한 응급 상황에서 유용하며, 의사가 신속하게 적절한 치료를 시작할 수 있도록 해줍니다.
세그먼트 분석
전 세계 심근경색 진단 시장은 검사 유형, 최종 사용자 및 지역별로 세분화됩니다.
심전도(ECG) 부문은 예측 기간 동안 시장에서 지배적인 위치를 차지할 것으로 예상됩니다.
심전도 부문은 예측 기간 동안 전체 심근경색 진단 시장의 약 47.5%를 차지할 것으로 예상됩니다. ECG는 심장이 수축하고 이완할 때 발생하는 전기 신호를 측정하고 기록하여 심장의 전반적인 건강과 기능에 대한 중요한 데이터를 수집합니다. 또한, 이 부문은 주요 기업의 제품 출시와 기술 개선으로 인해 성장하고 있습니다.
예를 들어, 미국 FDA 승인을 받은 개인용 심전도(ECG) 기술 기업인 AliveCor는 2020년 9월 임상적으로 검증된 개인용 ECG 장치인 KardiaMobile 6L을 출시하며 인도 시장에 진출했습니다. 개인용 심전도(ECG) 장치는 전 세계에서 유일하게 FDA 승인을 받은 6리드 개인용 ECG 장치입니다. 이 장치를 사용하면 가장 흔한 세 가지 부정맥 또는 비정상적인 심장 박동인 심방세동(AFib), 서맥 및 빈맥을 모두 진단할 수 있습니다.
지역 분석
유럽은 예측 기간 동안 전 세계 심근경색 진단 시장에서 두 번째로 큰 점유율을 차지할 것으로 예상됩니다.
유럽 지역은 예측 기간 동안 전 세계 심근경색 진단 시장에서 약 32.1%의 점유율을 차지하며 두 번째로 큰 시장 점유율을 기록할 것으로 예상됩니다.
관상동맥 질환(CAD) 및 말초 동맥 질환 환자 수가 지속적으로 증가함에 따라 전 세계 심근경색 진단 시장은 꾸준히 성장하고 있습니다. 2022년 3월 유럽 연합(EU)의 자료에 따르면 심근경색은 EU에서 주요 사망 원인이었습니다.
또한 기술 발전으로 검사 장비의 휴대성이 향상되어 시장 매출 확대를 뒷받침하고 있습니다. 킹스 칼리지 런던은 심장마비를 진단하고 트로포닌 대신 MyC 혈중 농도를 높여 환자의 심장마비 가능성을 신속하게 배제하기 위해 혁신적인 혈액 검사 기기를 개발했습니다.
경쟁 환경
이 시장의 주요 글로벌 업체로는 F Hoffmann-La Roche Ltd, Hitachi Medical Systems, GE Healthcare, Schiller AG, Siemens Healthineers, HeartFlow, Beckman Coulter, Inc., Medtronic, Cardio Diagnostics Holdings Inc, Midmark Corporation 등이 있습니다.
보고서 구매 이유

• 제품, 적용 분야, 지역별 글로벌 심장마비 진단 시장 세분화를 시각화하고 주요 사업 자산 및 업체를 파악합니다.

• 트렌드 분석 및 공동 개발을 통해 사업 기회를 식별합니다.

• 모든 세그먼트를 포함한 심장마비 진단 시장 수준의 다양한 데이터가 담긴 Excel 데이터 시트를 제공합니다.

• 심층적인 질적 인터뷰와 연구를 바탕으로 종합적인 분석을 담은 PDF 보고서를 제공합니다.

• 주요 업체들의 핵심 제품을 모두 포함하는 제품 맵핑 Excel 파일을 제공합니다.

글로벌 심장마비 진단 시장 보고서는 약 53개의 표, 54개의 그림, 그리고 195페이지 분량으로 구성될 예정입니다.
주요 대상 고객 (2023년 기준)
• 제조업체/구매자
• 산업 투자자/투자 은행가
• 시장 조사 전문가
• 신흥 기업

보고서 요약(영어 원문)

Market Overview
The Global Heart Attack Diagnostics Market reached US$ 8,744.6 million in 2022 and is projected to witness lucrative growth by reaching up to US$ 15,605.3 million by 2030. The global heart attack diagnostics market is expected to exhibit a CAGR of 7.7% during the forecast period (2023-2030).
The global heart attack diagnostics market is influenced by a number of variables, including dietary habits, environmental exposures, and genetic susceptibility. These elements can increase the risk of cardiovascular disease by causing high blood pressure, high cholesterol, obesity, and diabetes.
Heart attacks also are greatly influenced by unhealthy habits including smoking, drinking too much alcohol, and eating a lot of fast food. The prevalence of heart attacks among the population has increased as a result of the adoption of these harmful habits.
Market Dynamics
Adoption of Important Measures Used in New Product Launches
Heart attack diagnostics market expansion is being fueled by elements including rising healthcare spending, partnerships and collaborations between leading players, and increased R&D.
For instance, in November 2022, Heartbeat Health, the nation's largest virtual-first cardiovascular company, and Cleerly, the startup developing a new standard of care for heart illness, announced a partnership to employ precision heart health to more precisely evaluate cardiovascular risk and provide better heart care. Physicians may more quickly recognize, describe, and measure atherosclerosis (plaque buildup) in the walls of heart arteries thanks to Cleerly's AI-enabled approach for analyzing coronary computed tomography angiography (CCTA).
Additionally, in November 2022, CardioSignal and OMRON Healthcare, a manufacturing and sales of automation components, equipment and systems company, joined forces to serve doctors at the forefront of population health management by delivering breakthroughs in early cardiovascular disease detection to them.
The two businesses will work together to develop digital health solutions that enhance workflow procedures for lifestyle chronic diseases, particularly for the primary care identification of cardiovascular disease. Key players' strategies serve to propel the market in such a manner.
Lack of a Skilled Workforce will Hamper the Market Growth
A team of highly certified, skilled, and experienced healthcare experts is needed to carry out an efficient cardiac catheterization operation because it is a challenging treatment that demands a high level of precision and accuracy.
It is anticipated that throughout the projection period, market expansion will be somewhat constrained by a dearth of skilled specialists to perform coronary angiograms, particularly in emerging nations due to the absence of comprehensive training programs.
COVID-19 Impact Analysis
The SARS-CoV-2 virus epidemic led to a global lockdown and had a disastrous impact on heart attack diagnosis. People with heart conditions are more likely to develop the virus, especially those who are prone to heart attacks, and if the infection is not identified early enough, there is a high likelihood that they will die.
Additionally, there are significant worries regarding the long-term deterioration of cardiovascular health outcomes as a result of a lack of prompt diagnosis. There aren't many different parties involved in patient access to cardiovascular diagnosis and treatment.
Russia-Ukraine War Impact Analysis
The Russia-Ukraine is estimated to have a minimal impact on the global heart attack diagnostics market owing to the absence of key market players in this region. However, the impact of the import and export of raw materials, test products, and devices is anticipated to have little influence over the global heart attack diagnostics market in the forecast period.
Artificial Intelligence Impact Analysis
Artificial intelligence is anticipated to impact the global heart attack diagnostics market positively. Because AI algorithms can analyze vast amounts of patient data, including medical records, lab results, imaging scans, and genetic information. By processing this data, AI can identify patterns and subtle indicators that may go unnoticed by human physicians, leading to more accurate and reliable diagnoses of heart attacks.
AI algorithms can analyze data in real-time, providing rapid and accurate diagnosis of heart attacks. This can be particularly useful in emergency situations where time is critical, allowing doctors to quickly begin appropriate treatment
Segment Analysis
The global heart attack diagnostics market is segmented based on test type, end-user, and region.
The Electrocardiogram Segment is Expected to Hold a Dominant Position in the Market Over the Forecast Period
The electrocardiogram segment holds about 47.5% of the total heart attack diagnostics market in the forecast period. ECG gathers crucial data on the general health and performance of the heart by measuring and documenting the electrical signals the heart produces as it contracts and relaxes. Additionally, the segment is growing as a result of the leading companies' product launches and technological improvements.
For instance, in September 2020, AliveCor, a personal electrocardiogram (ECG) technology business with US FDA clearance, made its entry into the Indian market with the release of KardiaMobile 6L, a clinically-validated personal ECG device. The personal ECG device is the only six-lead, FDA-approved personal ECG device available in the world. Atrial fibrillation (AFib), bradycardia, and tachycardia, the three most prevalent arrhythmias or abnormal heartbeats, can all be found using this device.
Geographical Analysis
Europe is Estimated To Hold the Second-largest Share Of The Global Heart Attack Diagnostics Market During The Forecast Period.
The Europe region holds the second largest share of the global heart attack diagnostics market accounting for approximately 32.1% in the forecast period.
Due to a constant increase in the number of patients with CAD and peripheral artery disorders, the market for global heart attack diagnostics is continuously witnessing growth. According to results made available by the European Union in March 2022, heart attacks were a significant cause of fatalities in the EU.
Additionally, technical developments are enabling portable characteristics in testing equipment, supporting the expansion of the market's revenue. In order to diagnose heart attacks and raise blood levels of MyC rather than troponin to rapidly rule out the possibility of heart attacks in patients, Kings College London created a novel blood test gadget.
Competitive Landscape
The major global players in the market include F Hoffmann-La Roche Ltd, Hitachi Medical Systems, GE Healthcare, Schiller AG, Siemens Healthineers, HeartFlow, Beckman Coulter, Inc., Medtronic, Cardio Diagnostics Holdings Inc, and Midmark Corporation, among others.
Why Purchase the Report?
• To visualize the global heart attack diagnostics market segmentation based on product, application, and region and understand key commercial assets and players.
• Identify commercial opportunities by analyzing trends and co-development.
• Excel data sheet with numerous data points of heart attack diagnostics market-level with all segments.
• PDF report consists of a comprehensive analysis after exhaustive qualitative interviews and an in-depth study.
• Product mapping available as Excel consisting of key products of all the major players.
The global heart attack diagnostics market report would provide approximately 53 tables,54 figures, and 195 Pages.
Target Audience 2023
• Manufacturers/ Buyers
• Industry Investors/Investment Bankers
• Research Professionals
• Emerging Companies

상세 목차

1. Methodology and Scope
1.1. Research Methodology
1.2. Research Objective and Scope of the Report
2. Definition and Overview
3. Executive Summary
3.1. Snippet by Test Type
3.2. Snippet by End User
3.3. Snippet by Region
4. Dynamics
4.1. Impacting Factors
4.1.1. Drivers
4.1.1.1. The high prevalence of cardiovascular diseases is expected to drive the market
4.1.1.2. Technological advancements in heart attack diagnostics devices
4.1.2. Restraints
4.1.2.1. Lack of skilled workforce will hamper the market growth
4.1.3. Opportunity
4.1.3.1. The development of more sophisticated imaging techniques, such as cardiac MRI
4.1.4. Impact Analysis
5. Industry Analysis
5.1. Porter's 5 Forces Analysis
5.2. Supply Chain Analysis
5.3. Unmet Needs
5.4. Epidemiology Analysis
6. COVID-19 Analysis
6.1. Analysis of COVID-19
6.1.1. Scenario Before COVID-19
6.1.2. Scenario During COVID-19
6.1.3. Scenario Post COVID-19
6.2. Pricing Dynamics Amid COVID-19
6.3. Demand-Supply Spectrum
6.4. Government Initiatives Related to the Market During the Pandemic
6.5. Manufacturers’ Strategic Initiatives
6.6. Conclusion
7. Russia-Ukraine War Analysis
8. Artificial Intelligence Impact Analysis
9. By Test Type
9.1. Introduction
9.1.1. Market Size Analysis and Y-o-Y Growth Analysis (%), By Test Type
9.1.2. Market Attractiveness Index, By Test Type
9.2. Electrocardiogram
9.2.1. Introduction
9.2.2. Market Size Analysis and Y-o-Y Growth Analysis (%)
9.3. Blood Tests
9.4. Angiogram
9.5. Computerized Cardiac Tomography
9.6. Magnetic Resonance Imaging (MRI)
9.7. Others
10. By End User
10.1. Introduction
10.1.1. Market Size Analysis and Y-o-Y Growth Analysis (%), By End User
10.1.2. Market Attractiveness Index, By End User
10.1.3. Hospitals
10.1.4. Introduction
10.1.5. Market Size Analysis and Y-o-Y Growth Analysis (%)
10.2. Ambulatory Surgical Centers
10.3. Diagnostics Centers
10.4. Cardiac Centers
10.5. Others
11. By Region
11.1. Introduction
11.1.1. Market Size Analysis and Y-o-Y Growth Analysis (%), By Region
11.1.2. Market Attractiveness Index, By Region
11.2. North America
11.2.1. Introduction
11.2.2. Key Region-Specific Dynamics
11.2.3. Market Size Analysis and Y-o-Y Growth Analysis (%), By Test Type
11.2.4. Market Size Analysis and Y-o-Y Growth Analysis (%), By End User
11.2.5. Market Size Analysis and Y-o-Y Growth Analysis (%), By Country
11.2.5.1. The U.S.
11.2.5.2. Canada
11.2.5.3. Mexico
11.3. Europe
11.3.1. Introduction
11.3.2. Key Region-Specific Dynamics
11.3.3. Market Size Analysis and Y-o-Y Growth Analysis (%), By Test Type
11.3.4. Market Size Analysis and Y-o-Y Growth Analysis (%), By End User
11.3.5. Market Size Analysis and Y-o-Y Growth Analysis (%), By Country
11.3.5.1. Germany
11.3.5.2. The U.K.
11.3.5.3. France
11.3.5.4. Italy
11.3.5.5. Spain
11.3.5.6. Rest of Europe
11.4. South America
11.4.1. Introduction
11.4.2. Key Region-Specific Dynamics
11.4.3. Market Size Analysis and Y-o-Y Growth Analysis (%), By Test Type
11.4.4. Market Size Analysis and Y-o-Y Growth Analysis (%), By End User
11.4.5. Market Size Analysis and Y-o-Y Growth Analysis (%), By Country
11.4.5.1. Brazil
11.4.5.2. Argentina
11.4.5.3. Rest of South America
11.5. Asia-Pacific
11.5.1. Introduction
11.5.2. Key Region-Specific Dynamics
11.5.3. Market Size Analysis and Y-o-Y Growth Analysis (%), By Test Type
11.5.4. Market Size Analysis and Y-o-Y Growth Analysis (%), By End User
11.5.5. Market Size Analysis and Y-o-Y Growth Analysis (%), By Country
11.5.5.1. China
11.5.5.2. India
11.5.5.3. Japan
11.5.5.4. Australia
11.5.5.5. Rest of Asia-Pacific
11.6. Middle East and Africa
11.6.1. Introduction
11.6.2. Key Region-Specific Dynamics
11.6.3. Market Size Analysis and Y-o-Y Growth Analysis (%), By Test Type
11.6.4. Market Size Analysis and Y-o-Y Growth Analysis (%), By End User
12. Competitive Landscape
12.1. Competitive Scenario
12.2. Market Share Analysis
12.3. Mergers and Acquisitions Analysis
13. Company Profiles
13.1. F Hoffmann-La Roche Ltd
13.1.1. Company Overview
13.1.2. Product Portfolio and Description
13.1.3. Financial Overview
13.1.4. Key Developments
13.2. Hitachi Medical Systems
13.3. GE Healthcare
13.4. Schiller AG
13.5. Siemens Healthineers
13.6. HeartFlow
13.7. Beckman Coulter, Inc.
13.8. Medtronic
13.9. Cardio Diagnostics Holdings Inc
13.10. Midmark Corporation.
LIST NOT EXHAUSTIVE
14. Appendix
14.1. About Us and Services
14.2. Contact Us

언급된 주요 기업들

F Hoffmann-La Roche Ltd, 4.	Key Developments, Hitachi Medical Systems, GE Healthcare, Schiller AG, Siemens Healthineers, HeartFlow, Beckman Coulter, Inc., Medtronic, Cardio Diagnostics Holdings Inc, Midmark Corporation.

표 목록 (Tables)

List of Tables

Table 1 Global Heart Attack Diagnostics Market Value, By Test Type, 2022, 2026 & 2030 (US$ Million)

Table 2 Global Heart Attack Diagnostics Market Value, By End User, 2022, 2026 & 2030 (US$ Million)

Table 3 Global Heart Attack Diagnostics Market Value, By Region, 2022, 2026 & 2030 (US$ Million)

Table 4 Global Heart Attack Diagnostics Market Value, By Test Type, 2022, 2026 & 2030 (US$ Million)

Table 5 Global Heart Attack Diagnostics Market Value, By Test Type, 2021-2030 (US$ Million)

Table 6 Global Heart Attack Diagnostics Market Value, By End User, 2022, 2026 & 2030 (US$ Million)

Table 7 Global Heart Attack Diagnostics Market Value, By End User, 2021-2030 (US$ Million)

Table 8 Global Heart Attack Diagnostics Market Value, By Region, 2022, 2026 & 2030 (US$ Million)

Table 9 Global Heart Attack Diagnostics Market Value, By Region, 2021-2030 (US$ Million)

Table 10 North America Heart Attack Diagnostics Market Value, By Test Type, 2021-2030 (US$ Million)

Table 11 North America Heart Attack Diagnostics Market Value, By End User, 2021-2030 (US$ Million)

Table 12 North America Heart Attack Diagnostics Market Value, By Country, 2021-2030 (US$ Million)

Table 13 South America Heart Attack Diagnostics Market Value, By Test Type, 2021-2030 (US$ Million)

Table 14 South America Heart Attack Diagnostics Market Value, By End User, 2021-2030 (US$ Million)

Table 15 South America Heart Attack Diagnostics Market Value, By Country, 2021-2030 (US$ Million)

Table 16 Europe Heart Attack Diagnostics Market Value, By Test Type, 2021-2030 (US$ Million)

Table 17 Europe Heart Attack Diagnostics Market Value, By End User, 2021-2030 (US$ Million)

Table 18 Europe Heart Attack Diagnostics Market Value, By Country, 2021-2030 (US$ Million)

Table 19 Asia-Pacific Heart Attack Diagnostics Market Value, By Test Type, 2021-2030 (US$ Million)

Table 20 Asia-Pacific Heart Attack Diagnostics Market Value, By End User, 2021-2030 (US$ Million)

Table 21 Asia-Pacific Heart Attack Diagnostics Market Value, By Country, 2021-2030 (US$ Million)

Table 22 Middle East & Africa Heart Attack Diagnostics Market Value, By Test Type, 2021-2030 (US$ Million)

Table 23 Middle East & Africa Heart Attack Diagnostics Market Value, By End User, 2021-2030 (US$ Million)

Table 24 F Hoffmann-La Roche Ltd: Overview

Table 25 F Hoffmann-La Roche Ltd: Product Portfolio

Table 26 F Hoffmann-La Roche Ltd: Key Developments

Table 27 Hitachi Medical Systems: Overview

Table 28 Hitachi Medical Systems: Product Portfolio

Table 29 Hitachi Medical Systems: Key Developments

Table 30 GE Healthcare: Overview

Table 31 GE Healthcare: Product Portfolio

Table 32 GE Healthcare: Key Developments

Table 33 Schiller AG: Overview

Table 34 Schiller AG: Product Portfolio

Table 35 Schiller AG: Key Developments

Table 36 Siemens Healthineers: Overview

Table 37 Siemens Healthineers: Product Portfolio

Table 38 Siemens Healthineers: Key Developments

Table 39 HeartFlow: Overview

Table 40 HeartFlow: Product Portfolio

Table 41 HeartFlow: Key Developments

Table 42 Beckman Coulter, Inc.: Overview

Table 43 Beckman Coulter, Inc.: Product Portfolio

Table 44 Beckman Coulter, Inc.: Key Developments

Table 45 Medtronic: Overview

Table 46 Medtronic: Product Portfolio

Table 47 Medtronic: Key Developments

Table 48 Cardio Diagnostics Holdings Inc: Overview

Table 49 Cardio Diagnostics Holdings Inc: Product Portfolio

Table 50 Cardio Diagnostics Holdings Inc: Key Developments

Table 51 Midmark Corporation: Overview

Table 52 Midmark Corporation: Product Portfolio

Table 53 Midmark Corporation: Key Developments

그림 목록 (Figures)

List of Figures

Figure 1 Global Heart Attack Diagnostics Market Value, 2021-2030 (US$ Million)

Figure 2 Global Heart Attack Diagnostics Market Share, By Test Type, 2022 & 2030 (%)

Figure 3 Global Heart Attack Diagnostics Market Share, By End User, 2022 & 2030 (%)

Figure 4 Global Heart Attack Diagnostics Market Share, By, 2022 & 2030 (%)

Figure 5 Global Heart Attack Diagnostics Market Share, By, 2022 & 2030 (%)

Figure 6 Global Heart Attack Diagnostics Market Share, By, 2022 & 2030 (%)

Figure 7 Global Heart Attack Diagnostics Market Share, By, 2022 & 2030 (%)

Figure 8 Global Heart Attack Diagnostics Market Share, By, 2022 & 2030 (%)

Figure 9 Global Heart Attack Diagnostics Market Share, By Region, 2022 & 2030 (%)

Figure 10 Global Heart Attack Diagnostics Market Y-o-Y Growth, By Test Type, 2022-2030 (%)

Figure 11 Electrocardiogram Heart Attack Diagnostics Market Value, 2021-2030 (US$ Million)

Figure 12 Blood Tests Heart Attack Diagnostics Market Value, 2021-2030 (US$ Million)

Figure 13 Angiogram Heart Attack Diagnostics Market Value, 2021-2030 (US$ Million)

Figure 14 Computerized Cardiac Tomography Heart Attack Diagnostics Market Value, 2021-2030 (US$ Million)

Figure 15 Magnetic Resonance Imaging (MRI) Heart Attack Diagnostics Market Value, 2021-2030 (US$ Million)

Figure 16 Others Heart Attack Diagnostics Market Value, 2021-2030 (US$ Million)

Figure 17 Global Heart Attack Diagnostics Market Y-o-Y Growth, By End User, 2022-2030 (%)

Figure 18 Hospitals End User in Global Heart Attack Diagnostics Market Value, 2021-2030 (US$ Million)

Figure 19 Ambulatory Surgical Centers End User in Global Heart Attack Diagnostics Market Value, 2021-2030 (US$ Million)

Figure 20 Diagnostics Centers End User in Global Heart Attack Diagnostics Market Value, 2021-2030 (US$ Million)

Figure 21 Cardiac Centers End User in Global Heart Attack Diagnostics Market Value, 2021-2030 (US$ Million)

Figure 22 Others End User in Global Heart Attack Diagnostics Market Value, 2021-2030 (US$ Million)

Figure 23 End User in Global Heart Attack Diagnostics Market Value, 2021-2030 (US$ Million)

Figure 24 End User in Global Heart Attack Diagnostics Market Value, 2021-2030 (US$ Million)

Figure 25 Global Heart Attack Diagnostics Market Y-o-Y Growth, By Region, 2022-2030 (%)

Figure 26 North America Heart Attack Diagnostics Market Value, 2021-2030 (US$ Million)

Figure 27 Asia-Pacific Heart Attack Diagnostics Market Value, 2021-2030 (US$ Million)

Figure 28 Europe Heart Attack Diagnostics Market Value, 2021-2030 (US$ Million)

Figure 29 South America Heart Attack Diagnostics Market Value, 2021-2030 (US$ Million)

Figure 30 Middle East and Africa Heart Attack Diagnostics Market Value, 2021-2030 (US$ Million)

Figure 31 North America Heart Attack Diagnostics Market Value, 2021-2030 (US$ Million)

Figure 32 North America Heart Attack Diagnostics Market Share, By Test Type, 2022 & 2030 (%)

Figure 33 North America Heart Attack Diagnostics Market Share, By End User, 2022 & 2030 (%)

Figure 34 North America Heart Attack Diagnostics Market Share, By Country, 2022 & 2030 (%)

Figure 35 South America Heart Attack Diagnostics Market Value, 2021-2030 (US$ Million)

Figure 36 South America Heart Attack Diagnostics Market Share, By Test Type, 2022 & 2030 (%)

Figure 37 South America Heart Attack Diagnostics Market Share, By End User, 2022 & 2030 (%)

Figure 38 South America Heart Attack Diagnostics Market Share, By Country, 2022 & 2030 (%)

Figure 39 Europe Heart Attack Diagnostics Market Value, 2021-2030 (US$ Million)

Figure 40 Europe Heart Attack Diagnostics Market Share, By Test Type, 2022 & 2030 (%)

Figure 41 Europe Heart Attack Diagnostics Market Share, By End User, 2022 & 2030 (%)

Figure 42 Europe Heart Attack Diagnostics Market Share, By Country, 2022 & 2030 (%)

Figure 43 Asia-Pacific Heart Attack Diagnostics Market Value, 2021-2030 (US$ Million)

Figure 44 Asia-Pacific Heart Attack Diagnostics Market Share, By Test Type, 2022 & 2030 (%)

Figure 45 Asia-Pacific Heart Attack Diagnostics Market Share, By End User, 2022 & 2030 (%)

Figure 46 Asia-Pacific Heart Attack Diagnostics Market Share, By Country, 2022 & 2030 (%)

Figure 47 Middle East & Africa Heart Attack Diagnostics Market Value, 2021-2030 (US$ Million)

Figure 48 Middle East & Africa Heart Attack Diagnostics Market Share, By Test Type, 2022 & 2030 (%)

Figure 49 Middle East & Africa Heart Attack Diagnostics Market Share, By End User, 2022 & 2030 (%)

Figure 50 F Hoffmann-La Roche Ltd: Financials

Figure 51 Hitachi Medical Systems: Financials

Figure 52 GE Healthcare: Financials

Figure 53 Schiller AG: Financials

Figure 54 Siemens Healthineers: Financials

Figure 55 HeartFlow: Financials

Figure 56 Beckman Coulter, Inc.: Financials

Figure 57 Medtronic: Financials

Figure 58 Cardio Diagnostics Holdings Inc: Financials

Figure 59 Midmark Corporation: Financials

글로벌 심장마비 진단 시장 – 2023-2030

Global Heart Attack Diagnostics Market - 2023-2030